-
公开(公告)号:US07267949B2
公开(公告)日:2007-09-11
申请号:US10277413
申请日:2002-10-21
IPC分类号: C12Q1/68
CPC分类号: A61K45/06 , A61K31/445 , A61K31/4458 , A61K33/00 , Y10S514/81 , Y10S514/813 , Y10S514/922 , A61K2300/00
摘要: A process of treating a subject that is undergoing methylphenidate therapy and concomitant therapy with another drug undergoes or interferes with P450 metabolism, wherein the methylphenidate is d-threo-methylphenidate.
摘要翻译: 治疗正在进行哌甲酯治疗和伴随其他药物治疗的受试者的过程经历或干扰P u> 450代谢,其中哌甲酯是D-苏氨哌甲酯。
-
公开(公告)号:US06468504B1
公开(公告)日:2002-10-22
申请号:US09597384
申请日:2000-06-19
IPC分类号: A61K4900
CPC分类号: A61K45/06 , A61K31/445 , A61K31/4458 , A61K33/00 , Y10S514/81 , Y10S514/813 , Y10S514/922 , A61K2300/00
摘要: A process of treating a subject that is undergoing methylphenidate therapy and concomitant therapy with another drug undergoes or interferes with P450 metabolism, wherein the methylphenidate is d-threo-methylphenidate.
摘要翻译: 治疗正在接受哌甲酯治疗和与另一种药物并用治疗的受试者的过程发生或干扰P450代谢,其中哌甲酯是D-苏氨哌甲酯。
-
公开(公告)号:US6113879A
公开(公告)日:2000-09-05
申请号:US106870
申请日:1998-06-29
IPC分类号: C07D211/34 , A61K31/445 , A61K31/4458 , A61K33/00 , A61K45/00 , A61K45/06 , A61K49/00 , A01N33/02 , A01N43/06 , A61K9/16
CPC分类号: A61K45/06 , A61K31/445 , A61K31/4458 , A61K33/00 , Y10S514/81 , Y10S514/813 , Y10S514/922
摘要: A method of treating a subject that is undergoing methylphenidate therapy and concomitant therapy with another drug undergoes or interferes with P.sub.450 metabolism, wherein the methylphenidate is d-threo-methylphenidate.
摘要翻译: 治疗正在进行哌甲酯治疗和伴随其他药物治疗的受试者的方法经历或干扰P450代谢,其中哌甲酯是D-苏氨哌甲酯。
-
公开(公告)号:US5773478A
公开(公告)日:1998-06-30
申请号:US679878
申请日:1996-07-15
IPC分类号: C07D211/34 , A61K31/445 , A61K31/4458 , A61K33/00 , A61K45/00 , A61K45/06 , A01N33/02 , A01N43/06 , A61K9/16 , A61K31/135
CPC分类号: A61K45/06 , A61K31/445 , A61K31/4458 , A61K33/00 , Y10S514/81 , Y10S514/813 , Y10S514/922
摘要: A method of treating a subject that is undergoing methylphenidate therapy and concomitant therapy with another drug undergoes or interferes with P.sub.450 metabolism, wherein the methylphenidate is d-threo-methylphenidate.
-
-
-